Skip to main content
News Icon

News categories: Publication

Hair loss gene discovery

Hairlessness, skin changes, a strong hypersensitivity to light: these are the symptoms of the so-called IFAP syndrome. Scientists from the universities of Beijing, Hamburg and Bonn have now identified a genetic defect that triggers the rare disorder. The results have been published in the "American Journal of Human Genetics". IFAP syndrome is very rare; Probably not even 100 people in Germany suffer from this congenital disorder. Those affected are sparsely hairy to complete hairlessness, even eyebrows and eyelashes may be missing. The skin is often keratinized; Sunlight or strong artificial light hurts the eyes. The abbreviation "IFAP" stands for the medical names of these three key symptoms.

In the medium term, the study could also open up new ways of treating IFAP syndrome. Perhaps, for example, the lack of cholesterol in the skin can be improved by special fatty ointments. However, further studies have to show whether this really works. The results already provide an insight into the diverse processes that must work together for the healthy development of skin and hair.


Publication

Huijun Wang u.a.: Mutations in SREBF1, Encoding Sterol Regulatory Element Binding Transcription Factor 1, Cause Autosomal Dominant IFAP Syndrome; American Journal of Human Genetics; DOI: https://doi.org/10.1016/j.ajhg.2020.05.006

Associated cluster scientists: Regina Betz

Related news

Kathrin Leppek Publication PM

News categories: Publication

Starting points for the control of protein synthesis

The research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated control of gene expression. Researchers at the University Hospital Bonn (UKB) and the University of Bonn, in collaboration with Stanford University in California (USA), have now developed a toolbox as a new gold standard for this field. The results of their work have been published in The EMBO Journal.
View entry
Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry
AG Kürthen Multiple Sclerosis Bonn

News categories: Publication

Potential target for MS therapy discovered

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of white blood cell, play a role in the development of MS and are thus a target for therapies. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the FAU Erlangen-Nuremberg identified the membrane protein MLC1 as a potential target antigen in MS. The results of the work have now been published in the renowned journal “Neurology Neuroimmunology & Neuroinflammation”.
View entry

Back to the news overview